Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve Audited Results for Quarter and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Ltd has informed BSE that its Board of Directors will meet on Friday, 23rd May 2025. The main agenda is to consider and approve the audited standalone and consolidated financial results for the quarter and full year ended March 31, 2025. The company has also closed the trading window for designated persons from April 1, 2025 until 48 hours after the results are made public, in line with insider trading rules. No actual financial numbers have been disclosed yet — those will come after the board meeting. Investors should watch for the results announcement on or shortly after May 23, 2025.
This is a routine pre-results announcement and is not expected to move the stock on its own. The actual price reaction will depend on the audited numbers released after the board meeting on May 23, 2025.